Philippe Degive
Investment Manager @ S.R.I.W.
Philippe Degive is a Series A investor at S.R.I.W. focused on Health Care and Manufacturing. Philippe Degive is investment manager with Société Régionale d'Investissement de Wallonie (“S.R.I.W.”) SA. Created in 1979, the S.R.I.W. Group is an institution owned by the Walloon Government that assists entrepreneurs in creating and developing businesses in the Walloon region. Philippe is responsible for a portfolio of investments infunds and companies active in the pharmaceutical industry and biotechnology. He is also a director in a series of investee companies of S.R.I.W. Before joining S.R.I.W., Philippe headed Cedip Management SPRL, a company specialised in consulting to enterprises and corporate finance. He has been for more than 10 years a manager with Fortis Bank SA where he has held several responsible positions. He started his career with Petrofina SA.He has been involved in a wide range of transactions. He has also been a regular speaker for different organisations such as e.g. the Belgian banking association, the Liège University, the Chamber of Commerce etc ...
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Philippe Degive invests in
Stages Philippe Degive invests in
Countries Philippe Degive invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (33%)
- Manufacturing 1 (33%)
- Medical Device 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium.By 2012, iSTAR received ISO 13485 and ISO 9001 Quality SystemsCertifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant. | $44.1M / Series C / Sep 05, 2019 | ||
| iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium.By 2012, iSTAR received ISO 13485 and ISO 9001 Quality SystemsCertifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant. | $11.4M / Series B / Apr 12, 2016 | ||
| iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium.By 2012, iSTAR received ISO 13485 and ISO 9001 Quality SystemsCertifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant. | $4.4M / Series A / Nov 21, 2013 |
Co-Investors
About S.R.I.W.
The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.
S.R.I.W. Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Philippe Degive
Investment Manager
|
|||
Gery Lefebvre
Investment Manager
|
|||
|
Jean-Pascal LABILLE
Chairman
|
|||
Thibaut Claes
Investment Manager
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Philippe Degive invest in?
Philippe Degive invests primarily in Health Care, Manufacturing and Medical Device startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Philippe Degive?
Public channels for Philippe Degive include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Philippe Degive last invest?
The most recent investment recorded for Philippe Degive closed in Sep 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
